Long-Term Liabilities: The sum of all non-current liabilities.
Thermo Fisher Scientific Inc. (TMO) had Long-Term Liabilities of $37.99B for the most recently reported fiscal quarter, ending 2023-12-31.
Income Statement Financials | |
$10.89B |
|
$1.63B |
|
$6.49B |
|
$4.39B |
|
$9.03B |
|
$1.85B |
|
$-114.00M |
|
$1.74B |
|
$1.74B |
|
$1.61B |
|
$1.61B |
|
$1.61B |
|
$1.61B |
|
$1.85B |
|
$2.69B |
|
386.00M |
|
388.00M |
|
$4.21 |
|
$4.20 |
|
Balance Sheet Financials | |
$24.59B |
|
$9.45B |
|
$74.14B |
|
$98.73B |
|
$14.01B |
|
$31.31B |
|
Long-Term Liabilities |
$37.99B |
$52.00B |
|
$46.72B |
|
$-13.97B |
|
$46.72B |
|
386.65M |
|
Cash Flow Statement Financials | |
$8.41B |
|
$-5.14B |
|
$-3.62B |
|
$8.54B |
|
$8.10B |
|
$-440.00M |
|
$278.00M |
|
$-523.00M |
|
-- |
|
Fundamental Metrics & Ratios | |
1.75 |
|
-- |
|
-- |
|
0.40 |
|
0.75 |
|
40.35% |
|
17.03% |
|
17.03% |
|
-- |
|
15.98% |
|
14.97% |
|
$7.01B |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
1.28 |
|
1.32 |
|
67.97 |
|
3.44% |
|
-11.50% |
|
1.63% |
|
2.06% |
|
$120.84 |
|
$18.08 |
|
$21.66 |